[go: up one dir, main page]

SG11201501173SA - PI3Kδ INHIBITOR - Google Patents

PI3Kδ INHIBITOR

Info

Publication number
SG11201501173SA
SG11201501173SA SG11201501173SA SG11201501173SA SG11201501173SA SG 11201501173S A SG11201501173S A SG 11201501173SA SG 11201501173S A SG11201501173S A SG 11201501173SA SG 11201501173S A SG11201501173S A SG 11201501173SA SG 11201501173S A SG11201501173S A SG 11201501173SA
Authority
SG
Singapore
Prior art keywords
pi3kδ inhibitor
pi3kδ
inhibitor
Prior art date
Application number
SG11201501173SA
Inventor
Li Li
Yan Zhang
Original Assignee
Kbp Biosciences Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kbp Biosciences Co Ltd filed Critical Kbp Biosciences Co Ltd
Publication of SG11201501173SA publication Critical patent/SG11201501173SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11201501173SA 2012-08-08 2013-08-08 PI3Kδ INHIBITOR SG11201501173SA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201210279961 2012-08-08
CN201210529334 2012-12-10
CN201310130010 2013-04-16
PCT/CN2013/000934 WO2014023083A1 (en) 2012-08-08 2013-08-08 PI3Kδ INHIBITOR

Publications (1)

Publication Number Publication Date
SG11201501173SA true SG11201501173SA (en) 2015-05-28

Family

ID=50067418

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201501173SA SG11201501173SA (en) 2012-08-08 2013-08-08 PI3Kδ INHIBITOR
SG10202003090VA SG10202003090VA (en) 2012-08-08 2013-08-08 PI3K δ INHIBITOR

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202003090VA SG10202003090VA (en) 2012-08-08 2013-08-08 PI3K δ INHIBITOR

Country Status (3)

Country Link
CN (1) CN104768952B (en)
SG (2) SG11201501173SA (en)
WO (1) WO2014023083A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
RS55551B1 (en) 2004-05-13 2017-05-31 Icos Corp HINAZOLINONS AS HUMAN PHOSPHATIDYLINOSYTOL 3-KINASE DELTA INHIBITORS
RU2683793C2 (en) 2013-09-22 2019-04-02 Калитор Сайенсез, ЛЛС Substituted aminopyrimidine compounds and methods of use
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
US9567337B2 (en) 2013-12-20 2017-02-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
MX2016016516A (en) * 2014-06-13 2017-05-01 Gilead Sciences Inc Phosphatidylinositol 3-kinase inhibitors.
HK1231476A1 (en) * 2014-06-13 2017-12-22 吉利德科学公司 Phosphatidylinositol 3-kinase inhibitors
WO2015191745A1 (en) 2014-06-13 2015-12-17 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
NZ726055A (en) 2014-06-13 2018-04-27 Gilead Sciences Inc Quinazolinone derivatives as phosphatidylinositol 3-kinase inhibitors
CU24428B1 (en) 2014-07-04 2019-06-04 Lupin Ltd QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR101932146B1 (en) * 2016-07-14 2018-12-24 주식회사 바이오웨이 Novel Quinazolinone derivatives as PI3K inhibitors, and pharmaceutical composition comprising the same
TW201815787A (en) 2016-09-23 2018-05-01 美商基利科學股份有限公司 Phosphatidylinositol 3-kinase inhibitors
TW201825465A (en) 2016-09-23 2018-07-16 美商基利科學股份有限公司 Phosphatidylinositol 3-kinase inhibitors
TW201813963A (en) 2016-09-23 2018-04-16 美商基利科學股份有限公司 Phosphatidylinositol 3-kinase inhibitors
CN108003190B (en) * 2017-12-27 2020-06-12 东南大学 Preparation method of glufosinate-ammonium
CA3083040A1 (en) 2018-01-20 2019-07-25 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine compounds and methods of use
CN110283174B (en) * 2019-07-31 2021-07-23 安徽中医药大学 A class of PI3Kδ inhibitors and their uses
CN111440173B (en) * 2020-03-27 2021-05-14 山东大学 A kind of preparation method of PI3K inhibitor
CN115304600B (en) * 2022-09-29 2023-01-13 北京鑫开元医药科技有限公司 mTOR inhibitor, preparation method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020838A2 (en) * 2000-04-25 2004-12-31 Icos Corp Inhibitors of human phosphatidyl-inositol 3-kinase delta
RS55551B1 (en) * 2004-05-13 2017-05-31 Icos Corp HINAZOLINONS AS HUMAN PHOSPHATIDYLINOSYTOL 3-KINASE DELTA INHIBITORS
JP2008501707A (en) * 2004-06-04 2008-01-24 アイコス、コーポレーション Methods for treating mast cell disorders
CA2716334A1 (en) * 2007-11-13 2009-05-22 Icos Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
JP5869222B2 (en) * 2008-01-04 2016-02-24 インテリカイン, エルエルシー Specific chemical entities, compositions and methods
CN102838601A (en) * 2011-06-24 2012-12-26 山东亨利医药科技有限责任公司 Selective phosphatidylinositol-3 kinase delta inhibitor

Also Published As

Publication number Publication date
SG10202003090VA (en) 2020-05-28
WO2014023083A1 (en) 2014-02-13
CN104768952A (en) 2015-07-08
CN104768952B (en) 2016-10-19

Similar Documents

Publication Publication Date Title
SG11201501173SA (en) PI3Kδ INHIBITOR
LT2892889T (en) Inhibitor compounds
ZA201501974B (en) Ret inhibitor
ZA201407554B (en) Dna-pk inhibitors
ZA201503041B (en) Gdf-8 inhibitors
ZA201501009B (en) Imidazotriazinecarbonitriles useful as kinase inhibitors
IL239435A0 (en) Autotaxin inhibitors
EP2824184A4 (en) micro-RNA INHIBITOR
ZA201406225B (en) Thiadiazolidinediones as gsk-3 inhibitors
SG11201500973WA (en) Amino-quinolines as kinase inhibitors
IL239153A0 (en) Substituted pyridopyrazines as syk inhibitors
IL235919A0 (en) Fbxo3 inhibitors
GB201211019D0 (en) Inhibitor compounds
ZA201504305B (en) Autotaxin inhibitors
AP2015008541A0 (en) Autotaxin inhibitors
GB201213825D0 (en) Damper-device for bouncing-device
ZA201209168B (en) Descaling
AU345893S (en) Treehouse